Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem ; 16(1): 446-56, 2008 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-17905587

RESUMO

In the present communication, a new series of 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids (2a-p) have been synthesized. Benzaldehyde 4-phenyl-3-thiosemicarbazones substituted (1a-p) were also obtained and used as intermediate to give the title compounds. All synthesized compounds were characterized by IR, (1)H and (13)C NMR. The in vitro anti-Toxoplasma gondii activity of 1a-p and 2a-p was evaluated. The 4-thiazolidinones (2a-p) were screened for their in vitro antimicrobial activity. For anti-Toxoplasma gondii activity, in general, all compounds promoted decreases in the percentage of infected cells leading to parasite elimination. These effects on intracellular parasites also caused a decrease in the mean number of tachyzoites. In addition, most of the 4-thiazolidinones showed more effective toxicity against intracellular parasites, with IC(50) values ranging from 0.05 to 1 mM. According to results of antimicrobial activity, compounds 2f, 2l, and 2p showed best activity against Mycobacterium luteus, 2c was more active against Mycobacterium tuberculosis, and 2g, 2l, and 2n showed same activity as nistatin (standard drug) against Candida sp. (4249).


Assuntos
Anti-Infecciosos/síntese química , Antiprotozoários/síntese química , Tiazolidinas/síntese química , Tiossemicarbazonas/síntese química , Toxoplasma/efeitos dos fármacos , Animais , Anti-Infecciosos/farmacologia , Antiprotozoários/farmacologia , Candida/efeitos dos fármacos , Humanos , Concentração Inibidora 50 , Mycobacterium/efeitos dos fármacos , Mycobacterium tuberculosis/efeitos dos fármacos , Análise Espectral , Tiazolidinas/farmacologia , Tiossemicarbazonas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA